Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular genetics and human prostatic carcinoma.

V P Collins1, K Kunimi, U Bergerheim

  • 1Ludwig Institute for Cancer Research, Karolinska Hospital, Stockholm, Sweden.

Acta Oncologica (Stockholm, Sweden)
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis.

Rheumatology international·2021
Same author

Minor effect of loss to follow-up on outcome interpretation in the Swedish spine register.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2019
Same author

Long-term outcome after spinal fusion for isthmic spondylolisthesis in adults.

The spine journal : official journal of the North American Spine Society·2018
Same author

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.

Scandinavian journal of rheumatology·2017
Same author

Arterial stiffness is increased in young women with endometriosis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2014
Same author

Difference in the ratio of high-molecular weight (HMW) to total adiponectin and HMW adiponectin in late post-menopausal women.

Journal of endocrinological investigation·2013

Researchers identified genetic losses in prostate cancer using restriction fragment length polymorphism analysis. This study pinpoints chromosomal regions 8, 10, and 16 as potentially harboring tumor suppressor genes crucial for cancer development.

Area of Science:

  • Oncology
  • Molecular Genetics
  • Genomics

Background:

  • Molecular genetic techniques allow detailed characterization of clinical material.
  • Genetic abnormalities in tumors, particularly tumor suppressor genes, are a growing area of research.
  • Loss of gene function is a key factor in oncogenesis.

Purpose of the Study:

  • To characterize genetic abnormalities in prostate cancer.
  • To identify specific chromosomal regions with consistent genetic losses in tumor cells.
  • To lay the groundwork for localizing novel tumor suppressor genes.

Main Methods:

  • Utilized restriction fragment length polymorphism (RFLP) analysis.
  • Examined the genome of individual prostate cancer patients.
  • Identified deleted or rearranged regions within tumor cell genomes.

Related Experiment Videos

Main Results:

  • Preliminary findings indicate consistent losses of genetic information in prostate cancer.
  • Specific chromosomal regions showing significant loss include chromosomes 8, 10, and 16.
  • These losses suggest the presence of undiscovered tumor suppressor genes.

Conclusions:

  • Consistent genetic losses in prostate cancer are linked to specific chromosomal regions.
  • Chromosomes 8, 10, and 16 are implicated in prostate cancer development.
  • Further research can focus on these regions to identify novel tumor suppressor genes.